Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2194
http://purl.obolibrary.org/obo/NCIT_C2194
|
|---|---|
| Preferred Name | Sorafenib Tosylate |
| Definitions |
The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. |
|---|---|
| prefLabel | Sorafenib Tosylate
|
| label | Sorafenib Tosylate
|
| CHEBI_ID | CHEBI:50928
|
| PDQ_Closed_Trial_Search_ID | 299013
|
| code | C2194
|
| Has_Target |
See more
See less
|
| prefixIRI | NCIT:C2194
|
| in_subset |
See more
See less
|
| Display_Name | Sorafenib Tosylate
|
| Preferred_Name | Sorafenib Tosylate
|
| FDA_UNII_Code | 5T62Q3B36J
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C21H16ClF3N4O3.C7H8O3S
|
| Maps_To | Sorafenib Tosylate
|
| CAS_Registry | 475207-59-1
|
| NSC Number | 724772
|
| NCI_Drug_Dictionary_ID | 299013
|
| Legacy Concept Name | BAY_43-9006
|
| Has_Free_Acid_Or_Base_Form | |
| type | |
| ALT_DEFINITION | A drug used to treat advanced kidney cancer and a type of liver cancer that cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. Nexavar stops cells from dividing and may prevent the growth of new blood vessels that tumors need to grow. It is a type of kinase inhibitor and a type of antiangiogenesis agent.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 299013
|
| Accepted_Therapeutic_Use_For |
Major Depressive Disorder
Advanced renal cell carcinoma; Metastatic Colorectal Cancer
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C1676709
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |